The application of neoadjuvant chemotherapy in locally advanced breast cancer (LABC) has made it possible for LABC patients to receive breast conservation therapy (BCT). This paper overviews the current understanding in BCT for LABC patients, including its feasibility, indications and contraindications, and the relevant research progress in imaging assessment, existing problems and their solving strategies as well as postoperative radiotherapy and overall efficacy.